NGL Fine-Chem Limited Stock

Equities

NGLFINE

INE887E01022

Pharmaceuticals

Delayed Bombay S.E. 02:58:27 2024-04-18 am EDT 5-day change 1st Jan Change
2,540 INR +12.18% Intraday chart for NGL Fine-Chem Limited +16.00% +14.24%
Sales 2022 3.18B 38.02M Sales 2023 2.78B 33.3M Capitalization 7.39B 88.55M
Net income 2022 499M 5.98M Net income 2023 205M 2.46M EV / Sales 2022 3.81 x
Net Debt 2022 4.52M 54.18K Net cash position 2023 200M 2.4M EV / Sales 2023 2.59 x
P/E ratio 2022
24.2 x
P/E ratio 2023
36.1 x
Employees 396
Yield 2022
0.09%
Yield 2023
0.15%
Free-Float 25.12%
More Fundamentals * Assessed data
Dynamic Chart
1 day+12.58%
1 week+16.00%
Current month+21.97%
1 month+22.67%
3 months+29.58%
6 months+35.83%
Current year+14.24%
More quotes
1 week
2 085.90
Extreme 2085.9
2 572.10
1 month
1 987.40
Extreme 1987.4
2 572.10
Current year
1 790.00
Extreme 1790
2 572.10
1 year
1 293.65
Extreme 1293.65
2 572.10
3 years
1 161.35
Extreme 1161.35
3 789.45
5 years
220.00
Extreme 220
3 789.45
10 years
19.70
Extreme 19.7
3 789.45
More quotes
Managers TitleAgeSince
Chief Executive Officer 59 93-01-03
Director of Finance/CFO 48 05-05-31
Compliance Officer - 19-02-08
Members of the board TitleAgeSince
Chief Executive Officer 59 93-01-03
Director of Finance/CFO 48 05-05-31
Director/Board Member - 15-08-04
More insiders
Date Price Change Volume
24-04-18 2,540 +12.18% 4 706
24-04-16 2,264 +5.97% 1,300
24-04-15 2,137 -2.78% 1,146
24-04-12 2,198 -1.50% 420
24-04-10 2,231 -1.47% 508

Delayed Quote Bombay S.E., April 18, 2024 at 02:57 am EDT

More quotes
NGL Fine-Chem Limited is an India-based company, which is a manufacturer of pharmaceuticals and intermediates for use in veterinary and human health. The Company caters to various global companies to custom manufacture pharmaceuticals. Its products include APIs Animal Health, APIs Human Health, Intermediates and Specialty Chemicals and Finished Dosage Form. The APIs Animal Health products include Homidium Chloride, Nitroxynil, Clorsulon, Parvaquone, Buparvaquone, Isometamidium Chloride Hydrochloride, Toldimfos Sodium, Butaphosphan, Imidocarb Dipropionate, Triclabendazole, Rafoxanide, Diminazene Aceturate, S-Methoprene, Carprofen and others. The APIs Human Health products include Nitazoxanide and Atovaquone. The Intermediates and Specialty Chemicals product includes 1,4,7-Trimethyl-1,4,7-Triazacylononane and N-Ethyl Glucamine. The Finished Dosage Form products include Diminazene Aceturate Granules and Homidium Chloride Tablets. It has manufacturing plants located around Mumbai.
More about the company
  1. Stock Market
  2. Equities
  3. NGLFINE Stock